This inventor holds 1 USPTO granted patent. Top assignees: Idemitsu Kosan Company, Limited, National Center for Global Health and Medicine. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,283 
1 out of 16 Years Active: 2018
Title: Takashi Hamabata: Innovator in Vaccine Development
Introduction
Takashi Hamabata is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of vaccine development, particularly in addressing colibacillosis. His innovative approach has led to the creation of a unique fusion protein that combines elements of Shiga toxin and heat-labile toxin.
Latest Patents
Hamabata holds a patent for a vaccine against colibacillosis. This invention provides an agent for controlling the disease, showcasing his expertise in biotechnology and immunology. The patent highlights his commitment to advancing medical science and improving public health.
Career Highlights
Throughout his career, Takashi Hamabata has worked with prominent organizations, including Idemitsu Kosan Company, Limited and the National Center for Global Health and Medicine. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Takeshi Matsui and Kazutoshi Sawada. Their collaborative efforts have further enhanced the impact of Hamabata's work in vaccine research and development.
Conclusion
Takashi Hamabata's contributions to vaccine development, particularly his innovative approach to combating colibacillosis, underscore his importance in the field of biotechnology. His work continues to inspire future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile